Kei Sugiyama1, Tsutomu Inoue1, Eito Kozawa2, Masahiro Ishikawa3, Akira Shimada4, Naoki Kobayashi3, Junji Tanaka2, Hirokazu Okada1. 1. Department of Nephrology, Faculty of Medicine, Saitama Medical University, Saitama, Japan. 2. Department of Radiology, Faculty of Medicine, Saitama Medical University, Saitama, Japan. 3. School of Clinical Engineering, Faculty of Health and Medical Care, Saitama Medical University, Saitama, Japan. 4. Department of Endocrinology and Diabetes, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Abstract
BACKGROUND: Although chronic hypoxia and fibrosis may be a key to the progression of chronic kidney disease (CKD), a noninvasive means of measuring these variables is not yet available. Here, using blood oxygen level-dependent (BOLD) and diffusion-weighted (DW) magnetic resonance imaging (MRI), we assessed changes in renal tissue oxygenation and fibrosis, respectively, and evaluated their correlation with prognosis for renal function. METHODS: The study was conducted under a single-center, longitudinal, retrospective observational design. We examined the prognostic significance of T2* values of BOLD-MRI and apparent diffusion coefficient (ADC) values on DW-MRI and other clinical parameters. The rate of decline in estimated glomerular filtration rate (eGFR) was calculated by linear regression analysis using changes in eGFR during the observation period. RESULTS: A total of 91 patients were enrolled, with a mean age of 55.8 ± 15.6 years. Among patients, 51 (56.0%) were males and 38 (41.8%) had diabetes mellitus. The mean eGFR was 49.2 ± 28.9 mL/min/1.73 m2 and the mean observation period was 5.13 years. ADC values of DW-MRI but not T2* values of BOLD-MRI were well correlated with eGFR at the initial time point. The mean annual rate of decline in eGFR during the 5-year observation period was -1.92 ± 3.00 mL/min/1.73 m2. On multiple linear regression analysis, the rate of decline in eGFR was significantly correlated with eGFR at the start point, period average amount of proteinuria and T2* values, but not with ADC values (t = 2.980, P = 0.004). CONCLUSIONS: Reduced oxygenation as determined by low T2* values on BOLD-MRI is a clinically useful marker of CKD progression.
BACKGROUND: Although chronic hypoxia and fibrosis may be a key to the progression of chronic kidney disease (CKD), a noninvasive means of measuring these variables is not yet available. Here, using blood oxygen level-dependent (BOLD) and diffusion-weighted (DW) magnetic resonance imaging (MRI), we assessed changes in renal tissue oxygenation and fibrosis, respectively, and evaluated their correlation with prognosis for renal function. METHODS: The study was conducted under a single-center, longitudinal, retrospective observational design. We examined the prognostic significance of T2* values of BOLD-MRI and apparent diffusion coefficient (ADC) values on DW-MRI and other clinical parameters. The rate of decline in estimated glomerular filtration rate (eGFR) was calculated by linear regression analysis using changes in eGFR during the observation period. RESULTS: A total of 91 patients were enrolled, with a mean age of 55.8 ± 15.6 years. Among patients, 51 (56.0%) were males and 38 (41.8%) had diabetes mellitus. The mean eGFR was 49.2 ± 28.9 mL/min/1.73 m2 and the mean observation period was 5.13 years. ADC values of DW-MRI but not T2* values of BOLD-MRI were well correlated with eGFR at the initial time point. The mean annual rate of decline in eGFR during the 5-year observation period was -1.92 ± 3.00 mL/min/1.73 m2. On multiple linear regression analysis, the rate of decline in eGFR was significantly correlated with eGFR at the start point, period average amount of proteinuria and T2* values, but not with ADC values (t = 2.980, P = 0.004). CONCLUSIONS: Reduced oxygenation as determined by low T2* values on BOLD-MRI is a clinically useful marker of CKD progression.
Authors: Anand Srivastava; Xuan Cai; Jungwha Lee; Wei Li; Brett Larive; Cynthia Kendrick; Jennifer J Gassman; John P Middleton; James Carr; Kalani L Raphael; Alfred K Cheung; Dominic S Raj; Michel B Chonchol; Linda F Fried; Geoffrey A Block; Stuart M Sprague; Myles Wolf; Joachim H Ix; Pottumarthi V Prasad; Tamara Isakova Journal: Clin J Am Soc Nephrol Date: 2020-04-28 Impact factor: 8.237
Authors: Lu-Ping Li; Jon M Thacker; Wei Li; Bradley Hack; Chi Wang; Orly Kohn; Stuart M Sprague; Pottumarthi V Prasad Journal: Am J Nephrol Date: 2021-01-28 Impact factor: 3.754
Authors: Kim M Gooding; Chrysta Lienczewski; Massimo Papale; Niina Koivuviita; Marlena Maziarz; Anna-Maria Dutius Andersson; Kanishka Sharma; Paola Pontrelli; Alberto Garcia Hernandez; Julie Bailey; Kay Tobin; Virva Saunavaara; Anna Zetterqvist; David Shelley; Irvin Teh; Claire Ball; Sapna Puppala; Mark Ibberson; Anil Karihaloo; Kaj Metsärinne; Rosamonde E Banks; Peter S Gilmour; Michael Mansfield; Mark Gilchrist; Dick de Zeeuw; Hiddo J L Heerspink; Pirjo Nuutila; Matthias Kretzler; Matthew Welberry Smith; Loreto Gesualdo; Dennis Andress; Nicolas Grenier; Angela C Shore; Maria F Gomez; Steven Sourbron Journal: BMC Nephrol Date: 2020-06-29 Impact factor: 2.388
Authors: Lu-Ping Li; Alexander S Leidner; Emily Wilt; Artem Mikheev; Henry Rusinek; Stuart M Sprague; Orly F Kohn; Anand Srivastava; Pottumarthi V Prasad Journal: J Clin Med Date: 2022-04-01 Impact factor: 4.241